PIPages
Labs

Omid Veiseh

Rice University, TX·Biomedical Engineering

About 40% of breast cancer survivors develop breast cancer-related lymphedema (BCRL). In this lifelong condition, damaged lymphatic vessels (the drainage system that returns fluid from tissues) can no longer clear fluid, so the arm swells.

Fields

Biomedical Engineering

Materials Science

Medicine & Clinical Research

Topics

lymphedema

breast cancer survivorship

lymphatic regeneration

Grants
1 known grant, through Apr 2029

What they work on

  1. Make 3D alginate methacrylate (AlMA) hydrogels and optimize the dose of engineered cells that secrete VEGF-C, a lymphatic growth signal, to improve lymphatic vessel guidance and regeneration in living animals.
  2. Modify AlMA hydrogels with an anti-fibrotic small molecule so they resist the foreign body response, the immune scarring of implants, and keep the loaded cells alive in rodent models.
  3. Test whether the cell-loaded hydrogel graft restores lymph flow and reduces limb swelling in rodent and pig hindlimb lymphedema models.
  4. Use intravital microscopy, real-time imaging in living tissue, to study how the foreign body response and lymphatic regeneration unfold around the implant.

More about the research

There is no cure. Compression garments only manage symptoms and can cause infections and tissue damage. Microsurgery has its own limits, and engineered implants often trigger the foreign body response, an immune reaction that walls off implants with scar tissue (fibrosis). This multi-investigator project aims to build an implant that regrows lymphatic vessels without being rejected.

Why it matters

Breast cancer-related lymphedema affects about 40% of breast cancer survivors, and current care only manages symptoms. An implantable gel that resists rejection and releases a lymph-vessel growth signal could one day offer a way to restore fluid drainage instead of relying on lifelong compression. If preclinical results hold, this could reduce swelling, infections and hospital stays for these survivors.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Bioengineered lymphatic regenerating platform for treatment of breast cancer related lymphedema

NIH · Jun 2025 – Apr 2029

Closest labs

Ian Pitha

University of Utah, UT·Biomedical Engineering

Determine how glaucoma drainage implant composition, design and nanoscale surface architecture affect foreign-body and scarring (fibrotic) responses, using a versatile manufacturing platform that makes implants with varied materials and textures.

Aaron Morris

University of Michigan, MI·Biomedical Engineering·Early-career

Optimize hydrogel-based synthetic tertiary lymphoid structures (synTLS), 3D scaffolds that mimic immune tissue, and test how T cell receptor signals, stiffness, and metabolic cues affect conversion of T cells into stable Tregs.

Greg Harris

University of Cincinnati, OH·Biomedical Engineering

Quantify and control the electric potential generated by piezoelectric PVDF-TrFE scaffolds in response to remote ultrashock activation and mechanical stimulation.

The school

Rice University: 24 labs on PI Pages, $278M a year on research, 267 research doctorates a year.

More about Rice University

Reach out

A start for your email. Fill in the brackets.